검색어 : 통합검색[Essential cell biology : an introduction to the molecular biology of the cell]
-
51
-
Peptide Aptamer Microarrays: Bridging the bio–detector interface
-
Song, Qifeng;
Josef Stadler, Lukas Kurt;
Peng, Jianhe;
Ko Ferrigno, Paul;
Section of Experimental Therapeutics, Wellcome Trust Brenner Building, St James's University Hospital;
Section of Experimental Therapeutics, Wellcome Trust Brenner Building, St James's University Hospital;
Clinical and Biomedical Proteomics Group, Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James's University Hospital;
Section of Experimental Therapeutics, Wellcome Trust Brenner Building, St James's University Hospital;
(Faraday discussions,
v.149,
2011,
pp.79-92)
-
52
-
Indoleamine 2,3-Dioxygenase-1 Expressing Dendritic Cell Populations Are Associated with Tumor-Induced Immune Tolerance & Aggressive Disease Biology in Chronic Myelomonocytic Leukemia
-
Mangaonkar, Abhishek A.;
Reichard, Kaaren K.;
Chiu, April;
Howard, Matthew T;
King, Rebecca L;
Carr, Ryan M.;
Alver, Bonnie M;
Robertson, Keith D.;
Cousin, Margot;
Villasboas, Jose C;
Fernandez-Zapico, Martin E.;
Lasho, Terra L.;
Gangat, Naseema;
Al-Kali, Aref;
Elliott, Michelle A.;
Hogan, William J.;
Litzow, Mark R.;
Pardanani, Animesh;
Solary, Eric;
Tefferi, Ayalew;
Patnaik, Mrinal M.;
Division of Hematology, Mayo Clinic, Rochester, MN;
Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
Mayo Clinic, Rochester, MN;
Division of Hematopathology, Mayo Clinic, Rochester, MN;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
Division of Hematology, Mayo Clinic, Rochester, MN;
Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester,;
Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN;
Department of Health Sciences Research, Center for Individualized Medicine, Mayo Clinic, Rochester, MN;
Division of Hematology, Human Immune Monitoring Core, Mayo Clinic, Rochester, MN;
Department of Oncology, Mayo Clinic, Rochester, MN;
Division of Hematology, Mayo Clinic, Rochester, MN;
Division of Hematology, Mayo Clinic, Rochester, MN;
Division of Hematology and Medical Oncology, Department of Medicine, Mayo Clinic, Roches;
(Blood,
v.132,
2018,
pp.4344-4344)
-
53
-
Prediction of PP2A Holoenzymes Guided By the Structural Characterization of Methylation Independent PP2A Assembly
-
Wachter, Franziska;
Nowak, Radoslaw;
Fischer, Eric;
1Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA;
2Cancer Biology, Dana-Farber Cancer Institute, Boston, MA;
4Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA;
(Blood,
v.142,
2023,
pp.2802-2802)
-
54.
- Development of versatile technology for manipulation of large size DNA in Saccharomyces cerevisiae
- 김연희
-
Osaka University, 국외박사,
82p., 2005

6